These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35614027)

  • 21. Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series.
    Asoglu O; Bulut A; Aliyev V; Piozzi GN; Guven K; Bakır B; Goksel S
    World J Surg Oncol; 2022 Nov; 20(1):358. PubMed ID: 36352416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
    Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
    Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rise and fall of total mesorectal excision with lateral pelvic lymphadenectomy for rectal cancer: an updated systematic review and meta-analysis of 11,366 patients.
    Anania G; Davies RJ; Arezzo A; Bagolini F; D'Andrea V; Graziosi L; Di Saverio S; Popivanov G; Cheruiyot I; Cirocchi R; Donini A
    Int J Colorectal Dis; 2021 Nov; 36(11):2321-2333. PubMed ID: 34125269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transanal local excision versus intersphincteric resection for low rectal cancer with stage ypT0-1ycN0 after neoadjuvant chemoradiotherapy: an inverse probability weighting analysis for oncological and functional outcomes.
    Pan H; Gao Y; Ruan H; Chi P; Huang Y; Huang S
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17383-17394. PubMed ID: 37843558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T
    Serra-Aracil X; Pericay C; Golda T; Mora L; Targarona E; Delgado S; Reina A; Vallribera F; Enriquez-Navascues JM; Serra-Pla S; Garcia-Pacheco JC;
    Int J Colorectal Dis; 2018 Feb; 33(2):241-249. PubMed ID: 29234923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of transanal local excision of early rectal cancer on completion rectal resection without neoadjuvant chemoradiotherapy: a systematic review.
    Zinicola R; Nascimbeni R; Cirocchi R; Gagliardi G; Cracco N; Giuffrida M; Pedrazzi G; Binda GA
    Tech Coloproctol; 2021 Sep; 25(9):997-1010. PubMed ID: 34173121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score Analysis.
    Shin YS; Yu CS; Park JH; Kim JC; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Joo JH; Kim JH
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):136-144. PubMed ID: 28816139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer.
    Issa N; Murninkas A; Powsner E; Dreznick Z
    World J Surg; 2012 Oct; 36(10):2481-7. PubMed ID: 22736345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local excision of low rectal cancer treated by chemoradiotherapy: is it safe for all patients with suspicion of complete tumor response?
    Debove C; Guedj N; Tribillon E; Maggiori L; Zappa M; Panis Y
    Int J Colorectal Dis; 2016 Apr; 31(4):853-60. PubMed ID: 26951185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of direct-to-surgery lateral pelvic lymph node dissection for rectal cancer.
    Cribb B; Kong J; McCormick J; Warrier S; Heriot A
    Colorectal Dis; 2021 Jul; 23(7):1687-1698. PubMed ID: 33829629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local excision of rectal cancer followed by radical surgery because of poor prognostic features does not compromise the long term oncologic outcome.
    Gagliardi G; Newton TR; Bailey HR
    Colorectal Dis; 2013 Nov; 15(11):e659-64. PubMed ID: 24033889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local excision in rectal cancer patients with major or complete clinical response after neoadjuvant therapy: a case-matched study.
    Bushati M; Pucciarelli S; Gennaro N; Maretto I; Toppan P; Perin A; Urso EDL; Bagatella A; Spolverato G
    Int J Colorectal Dis; 2019 Dec; 34(12):2129-2136. PubMed ID: 31724079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonmetastatic ypt0 rectal cancer after neoadjuvant treatment and total mesorectal excision: Lessons from a retrospective multicentric cohort of 383 patients.
    Collard MK; Rullier E; Panis Y; Manceau G; Benoist S; Tuech JJ; Alves A; Laforest A; Mege D; Cazelles A; Beyer-Berjot L; Christou N; Cotte E; Lakkis Z; O'Connell L; Parc Y; Piessen G; Lefevre JH;
    Surgery; 2022 May; 171(5):1193-1199. PubMed ID: 35078629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
    Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
    Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
    Denost Q; Kontovounisios C; Rasheed S; Chevalier R; Brasio R; Capdepont M; Rullier E; Tekkis PP
    Eur J Surg Oncol; 2017 Jan; 43(1):92-99. PubMed ID: 27717529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
    Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
    Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of tissue changes induced by neoadjuvant treatment in total mesorectal excision (TME): novel suggestions for determining TME quality.
    Kim JC; Park SH; Kim J; Kim CW; Park IJ; Yoon YS; Lee JL; Kim JH; Hong YS; Kim TW
    Int J Colorectal Dis; 2022 Jun; 37(6):1289-1300. PubMed ID: 35513539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.